Betamethasone - Promius Pharma

Drug Profile

Betamethasone - Promius Pharma

Alternative Names: Betamethasone dipropionate 0.05% spray; DFD-01; Sernivo

Latest Information Update: 02 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Promius Pharma
  • Class Anti-inflammatories; Antiallergics; Corticosteroids; Fluorinated steroids; Glucocorticoids; Small molecules
  • Mechanism of Action Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis

Most Recent Events

  • 01 Aug 2016 Promius Pharma completes a phase III trial for Plaque psoriasis in USA (Topical) (NCT02749799)
  • 01 Jun 2016 Launched for Plaque psoriasis in USA (Topical, 0.05% spray) - First global launch
  • 07 Feb 2016 Pooled data from two phase III studies released by Promius Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top